Nazia Nazam
Noida, UP 201301, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Targeting mitochondria as a potential therapeutic strategy against radioresistance in cancer.
Journal: Frontiers in oncology
Published: April 07, 2026
Upregulation of the lncRNA MEG3 in Metastatic Hepatoblastoma.
Journal: Cells
Published: January 23, 2026
PP2A activation targets MYCN in neuroblastoma.
Journal: Cell death & disease
Published: March 29, 2025
A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of TRIM29.
Journal: International journal of molecular sciences
Published: March 24, 2025
Deciphering Pharmacological Targets of Plumbagin in Cisplatin-resistant Ovarian Cancer Model using in vitro and in silico Approaches.
Journal: Current pharmaceutical design
Published: January 14, 2025
Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma.
Journal: Cancer immunology, immunotherapy : CII
Published: May 16, 2024
PP2A activation overcomes leptomeningeal dissemination in group 3 medulloblastoma.
Journal: The Journal of biological chemistry
Published: March 27, 2024
PIM Kinase Inhibition Sensitizes Neuroblastoma to Doxorubicin.
Journal: Journal of pediatric surgery
Published: February 13, 2024
PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma.
Journal: International journal of molecular sciences
Published: November 01, 2023
Gold Nanoparticles Inhibit PMA-Induced MMP-9 Expression via microRNA-204-5p Upregulation and Deactivation of NF-κBp65 in Breast Cancer Cells.
Journal: Biology
Published: April 14, 2023
Phenolic Acids-Mediated Regulation of Molecular Targets in Ovarian Cancer: Current Understanding and Future Perspectives.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 27, 2022
Last Updated: 09/26/2026